Diabetes Discovery Could Aid Treatment

Published Online: Friday, August 1, 2003

A new discovery in diabetes treatment may help patients with type 2 diabetes. In the July 17, 2003, issue of Science, researchers reported that they have discovered a family of molecules that acts on a key gene involved in blood sugar control. The molecules increase the activity of the gene that produces glucokinase, which is "the most important member of a family of kinases that maintain normal glucose levels in the body," said Joseph P. Grippo, PhD, director of metabolic diseases at Hoffmann-La Roche Inc and lead author of the study.

Glucokinase acts in 2 ways to keep blood sugar under control. It is activated when blood sugar levels go above normal after eating, increasing insulin secretion from the pancrease and stimulating the process of glucose metabolism in the liver. It is deactivated just as quickly, when blood glucose levels drop to normal, according to Dr. Grippo. "Thus we could control two very important points in the process of blood sugar control," he said.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues